Cargando…
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals
IMPORTANCE: Current guidelines advocate the use of marine-derived omega-3 fatty acids supplements for the prevention of coronary heart disease and major vascular events in people with prior coronary heart disease, but large trials of omega-3 fatty acids have produced conflicting results. OBJECTIVE:...
Autores principales: | Aung, Theingi, Halsey, Jim, Kromhout, Daan, Gerstein, Hertzel C., Marchioli, Roberto, Tavazzi, Luigi, Geleijnse, Johanna M., Rauch, Bernhard, Ness, Andrew, Galan, Pilar, Chew, Emily Y., Bosch, Jackie, Collins, Rory, Lewington, Sarah, Armitage, Jane, Clarke, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885893/ https://www.ncbi.nlm.nih.gov/pubmed/29387889 http://dx.doi.org/10.1001/jamacardio.2017.5205 |
Ejemplares similares
-
Dietary and Circulating Long‐Chain Omega‐3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long‐Term Follow‐Up of the Alpha Omega Cohort
por: Pertiwi, Kamalita, et al.
Publicado: (2021) -
Dietary protein intake and kidney function decline after myocardial infarction: the Alpha Omega Cohort
por: Esmeijer, Kevin, et al.
Publicado: (2019) -
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
por: Bowman, Louise, et al.
Publicado: (2018) -
Cardiovascular Risk Factors Accelerate Kidney Function Decline in Post−Myocardial Infarction Patients: The Alpha Omega Cohort Study
por: Esmeijer, Kevin, et al.
Publicado: (2018) -
917. Infectious Diseases Consult Improves Management of Candidemia
por: Stornelli, Nick, et al.
Publicado: (2022)